ESR1 and breast carcinoma: The correlation between E-cadherin expression and DOX proliferation inhibition was analyzed in both mouse and human ERα-negative breast cancer cells (4T-1 and MDA-MB-468) to clarify whether the cytotoxicity of DOX on breast cancer cells is associated with expression of E-cadherin.